Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HIF hydroxylation and the mammalian oxygen-sensing pathway
Michal Safran, William G. Kaelin Jr.
Michal Safran, William G. Kaelin Jr.
Published March 15, 2003
Citation Information: J Clin Invest. 2003;111(6):779-783. https://doi.org/10.1172/JCI18181.
View: Text | PDF
Perspective

HIF hydroxylation and the mammalian oxygen-sensing pathway

  • Text
  • PDF
Abstract

Authors

Michal Safran, William G. Kaelin Jr.

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Hydroxylation of HIF-α. HIF-α contains bHLH and PAS DNA-binding and hete...
Hydroxylation of HIF-α. HIF-α contains bHLH and PAS DNA-binding and heterodimerization domains as well as two modular transcriptional activation domains (N-TAD and C-TAD). In the presence of oxygen, HIF-α is hydroxylated on conserved prolyl residues within the ODD (note that only one of two potential hydroxylation sites is shown for simplicity) by members of the EGLN family and on a conserved asparaginyl residue within the C-TAD by FIH1. The former leads to the recruitment of the pVHL ubiquitin ligase complex and the latter to displacement of p300 and CBP coactivator proteins. Polyubiquitination by the pVHL complex, which contains Elongin B, Elongin C, Rbx1, Cul2, and an unidentified E2 ubiquitin-conjugating enzyme, leads to proteasomal degradation of HIF. Recruitment of the E2 is linked to neddylation of the Cul2 scaffolding protein. Note that the HIF-α residues that are ubiquitinated are not known. B, Elongin B; C, Elongin C; ?E2, unidentified E2 ubiquitin-conjugating enzyme; N8, Nedd8; OH, hydroxy group; P, prolyl residue; N, aspariginyl residue; Ub, ubiguitin; ODD, oxygen-dependent degradation domain.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts